D. Clemons

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Bruce L. Zuraw, William R. Lumry, Douglas Johnston et al. · Journal of Allergy and Clinical Immunology · 2020 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Emel Aygören‐Pürsün, Anette Bygum, Vesna Grivcheva‐Panovska et al. · New England Journal of Medicine · 2018 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The <scp>OPuS</scp>‐2 study

Marc A. Riedl, Emel Aygören‐Pürsün, James Baker et al. · Allergy · 2018 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

1130 THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-7977 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS

E. Läwitz, M. Rodríguez‐Torres, Melanie Cornpropst et al. · Journal of Hepatology · 2012 · 37 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Abstracts from the 10th C1-inhibitor deficiency workshop

Alvin H. Schmaier, Marco Cicardi, Avner Reshef et al. · Allergy Asthma and Clinical Immunology · 2017 · 10 citations · Full text

Medicine, Pharmacology, Hemostasis +8